This page shows the latest IVD news and features for those working in and with pharma, biotech and healthcare.
So far, the rapid test for SARS-CoV-2, the virus which cause COVID-19, has received CE-IVD approval in Europe and Medicines &Healthcare products Regulatory Agency (MHRA) approval in
Roche said a CE-IVD test is also available in markets accepting the CE mark, for patients with symptoms of COVID-19 in affected areas. ... CE marking indicates that an in vitro diagnostic (IVD) can be legally commercialised in the European Union.
Roche plans to develop, manufacture and commercialise its Avenio IVD test kits for both tissue and blood use on Illumina’s Next Seq 550Dx system, while Illumina continues to sell the
Report suggests IVD tests could be key to big savings. The NHS could shave up to £7bn off its estimated £22bn deficit by 2023 if it takes advantage of diagnostic tools, ... The report specifically evaluated the savings of three existing IVD tests -
scandal. The European Biopharmaceutical Enterprises (EBE) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) voiced qualified support for the new IVD regulations. ... However, the two trade bodies anticipate the added
The single use, in vitro diagnostic (IVD) device is said to be 99.7% accurate from three months after suspected exposure to the infection and provides an indication of personal HIV
More from news
Approximately 2 fully matching, plus 6 partially matching documents found.
The timing is far from ideal. EU Member States have adopted new In Vitro Diagnostics (IVD) and Medical Devices (MD) Regulations. ... As this is a significant overhaul of the existing EU directives, authorities and companies have five years to adapt to
Licence. Diagnostic products IVD. 75. Merck &Co / AstraZeneca. Licence. WEE1 kinase (MK-1775) for ovarian cancer.
Strengthening another of its business units, Roche's diagnostic arm announced a licensing deal with Pacific Bioscience for human in vitro diagnostic (IVD) gene sequencing technology, paying $35m upfront and additional
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...